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| INTRODUC TI ON
The World Health Organization (WHO) estimated that approximately 71 million people were living with chronic hepatitis C virus (HCV) worldwide and 399 000 people died from cirrhosis, hepatocellular carcinoma, and liver function failure caused by HCV infection in 2015. 1 Since 2016, direct-acting antivirals (DAAs) have been strongly recommended by WHO to all patients diagnosed with HCV infection, irrespective of genotype or disease stage. 2 Nowadays, HCV infection can be cured by antiviral treatment; however, many hepatitis C patients are asymptomatic, 3 and therefore, the screening of HCV infection is of great significance. And HCV serology test has been approved as a preliminary screening test for patients who were at high risk or have a history of HCV risk exposure. It is recommended to perform anti-HCV assay for initial detection of serological evidence of past or present infection prior to supplementary HCV RNA for evidence of viraemic infection. 1, 4 Rapid and accurate serology methods with high sensitivity and specificity are required for screening to identify patients with HCV infection in clinical practice.
Numerous methods have been developed to detect HCV antibodies, including ELISA, chemiluminescence, and electrochemiluminescence assays. [5] [6] [7] [8] Though with high sensitivity and accuracy, these methods exist certain disadvantages. For example, ELISA is time-consuming and laborious, and all the above immunoassays also require several washing steps as well as solid-phase immobilization of antibodies.
LiCA is an unusually robust and sensitive homogeneous doubleantigen sandwich immunoassay method based on nanoparticle pairs coated with antigens or antibodies and oxygen channeling, which is capable of rapid, accurate, sensitive quantitative determination of a wide range of analytes. 9 With the outstanding advantages, LiCA has been widely accepted by clinical laboratories for reliable determination of TSH, 10 HBsAg, 11 sIgE against egg white allergens, 12 and tumor markers (CEA, CA15-3, and PSA) 13 
| SUBJEC TS AND ME THODS

| Subjects
| Serum anti-HCV and HCV RNA determination
All serum samples were centrifuged at 2575 g for 10 minutes.
These fresh samples were determined for HCV antibody on the 
| Statistical analysis
All data were analyzed by statistical software SPSS 19.0 (SPSS Inc).
The sensitivity, specificity, positive predictive values (PPV), and negative predictive values (NPV) were calculated. The agreement between ChIVD LiCA 500 and Abbott Architect i2000SR assay for the detection of HCV antibody was evaluated based on the positive (Table 2) . (Table 3) . were used to calculate the sensitivity and specificity ( 
| Analysis of samples with inconsistent results by HCV RNA and RIBA
| Diagnostic performance of ChIVD LiCA 500 and Abbott Architect i2000SR anti-HCV assays for the detection of HCV infection
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